SCHEMBL6508352

SCHEMBL6508352

CCCC1(CCC)C(=O)C=Cc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
PKM P14618 2/20 0.38
PGR P06401 2/20 0.38
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PDE7A Q13946 1/20 0.33
ELANE P08246 2/20 0.32
KIF11 P52732 1/20 0.31
P2RX1 P51575 1/20 0.31
P2RX3 P56373 1/20 0.31
P2RX4 Q99571 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516819 0.81 ALDH1A1 (0.36) KDM4EPKMALDH1A1LMNAHSD17B10
SCHEMBL11838929 0.79 KDM4E (0.50) KDM4EPKMPGRKMT2ANPSR1
SCHEMBL11852375 0.71 KDM4E (0.49) KDM4EPKMKMT2ANPSR1ALDH1A1
SCHEMBL9266602 0.71 KCNQ2 (0.55) KDM4EALDH1A1LMNAMAPK1CYP1A2
SCHEMBL4235643 0.71 PDK2 (0.41) KDM4EPKMPGRKMT2AALDH1A1
SCHEMBL318349 0.70 MEN1 (0.40) KDM4EPKMPGRKMT2AALDH1A1
SCHEMBL18378582 0.69 KDM4E (0.36) KDM4EPKMPGRPDE7A
SCHEMBL11841380 0.69 ELANE (0.33) KDM4EPKMALDH1A1ELANE
SCHEMBL23924806 0.68 KDM4E (0.38) KDM4EPKMPDE7A
SCHEMBL8461309 0.68 KDM4E (0.41) KDM4EPKMKMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005019191-A2 1, 1-DIOXIDO-4H-1,2,4-BENZOTHIADIAZINE DERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER HCV POLYMERASE ZUR BEHANDLUNG VON HEPATITIS C ABBOTT LABORATORIES (US) 2005-03-03 WO claimed
WO-2005019191-A2 1, 1-DIOXIDO-4H-1,2,4-BENZOTHIADIAZINE DERIVATE UND VERWANDTE VERBINDUNGEN ALS INHIBITOREN DER HCV POLYMERASE ZUR BEHANDLUNG VON HEPATITIS C ABBOTT LABORATORIES (US) 2005-03-03 WO disclosed